Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase

被引:115
|
作者
Narvaiza, Inigo [1 ]
Linfesty, Daniel C. [1 ]
Greener, Benjamin N. [1 ]
Hakata, Yoshiyuki [2 ]
Pintel, David J. [3 ]
Logue, Eric [2 ]
Landau, Nathaniel R. [2 ]
Weitzman, Matthew D. [1 ]
机构
[1] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA
[2] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[3] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Life Sci Ctr, Columbia, MO 65212 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-STRANDED-DNA; HIV-1 REVERSE TRANSCRIPTION; RNA EDITING ENZYME; ADENOASSOCIATED VIRUS; ALU RETROTRANSPOSITION; CRYSTAL-STRUCTURE; FUNCTIONAL IMPLICATIONS; VIF PROTEIN; IN-VIVO;
D O I
10.1371/journal.ppat.1000439
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The APOBEC3 proteins form a multigene family of cytidine deaminases with inhibitory activity against viruses and retrotransposons. In contrast to APOBEC3G (A3G), APOBEC3A (A3A) has no effect on lentiviruses but dramatically inhibits replication of the parvovirus adeno-associated virus (AAV). To study the contribution of deaminase activity to the antiviral activity of A3A, we performed a comprehensive mutational analysis of A3A. By mutation of non-conserved residues, we found that regions outside of the catalytic active site contribute to both deaminase and antiviral activities. Using A3A point mutants and A3A/A3G chimeras, we show that deaminase activity is not required for inhibition of recombinant AAV production. We also found that deaminase-deficient A3A mutants block replication of both wild-type AAV and the autonomous parvovirus minute virus of mice (MVM). In addition, we identify specific residues of A3A that confer activity against AAV when substituted into A3G. In summary, our results demonstrate that deaminase activity is not necessary for the antiviral activity of A3A against parvoviruses.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Programmable C-to-U RNA editing using the human APOBEC3A deaminase
    Huang, Xinxin
    Lv, Junjun
    Li, Yongqin
    Mao, Shaoshuai
    Li, Zhifang
    Jing, Zhengyu
    Sun, Yidi
    Zhang, Xiaoming
    Shen, Shengxi
    Wang, Xinxin
    Di, Minghui
    Ge, Jianyang
    Huang, Xingxu
    Zuo, Erwei
    Chi, Tian
    EMBO JOURNAL, 2020, 39 (22):
  • [42] Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
    Zhao, Kailiang
    Zhang, Qiang
    Flanagan, Sheryl A.
    Lang, Xueting
    Jiang, Long
    Parsels, Leslie A.
    Parsels, Joshua D.
    Zou, Weiping
    Lawrence, Theodore S.
    Buisson, Remi
    Green, Michael D.
    Morgan, Meredith A.
    MOLECULAR CANCER RESEARCH, 2021, 19 (09) : 1571 - 1582
  • [43] Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains
    Hakata, Yoshiyuki
    Landau, Nathaniel R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) : 36624 - 36631
  • [44] The cytidine deaminase APOBEC3B is a regulator of gene expression in breast cancer
    Periyasamy, Manikandan
    CANCER RESEARCH, 2017, 77
  • [45] Editing of hepatitis B virus DNA by the cytidine deaminase APOBEC3G.
    Rosler, C
    Kock, J
    Blum, HE
    von Weizsacker, F
    HEPATOLOGY, 2004, 40 (04) : 593A - 593A
  • [46] Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes
    Sanchez, Ambrocio
    Ortega, Pedro
    Buisson, Remi
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2024, 65 : 54 - 54
  • [47] A novel deaminase independent function of APOBEC3A catalyzes widespread chromosomal instability to drive an aggressive metastatic phenotype in pancreatic cancer
    Woermann, Sonja Maria
    Cowan, Robert
    Ross, Susan M.
    Rhim, Andrew D.
    CANCER RESEARCH, 2019, 79 (24)
  • [48] Human APOBEC1 cytidine deaminase edits HBV DNA
    Gonzalez, Minerva Cervantes
    Suspene, Rodolphe
    Henry, Michel
    Guetard, Denise
    Wain-Hobson, Simon
    Vartanian, Jean-Pierre
    RETROVIROLOGY, 2009, 6 : 96
  • [49] CYTIDINE AND DEOXYCYTIDYLATE DEAMINASE INHIBITION BY URIDINE ANALOGS
    DRAKE, JC
    HANDE, KR
    FULLER, RW
    CHABNER, BA
    BIOCHEMICAL PHARMACOLOGY, 1980, 29 (05) : 807 - 811
  • [50] Human APOBEC1 cytidine deaminase edits HBV DNA
    Minerva Cervantes Gonzalez
    Rodolphe Suspène
    Michel Henry
    Denise Guétard
    Simon Wain-Hobson
    Jean-Pierre Vartanian
    Retrovirology, 6